Cargando…

P1576: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU-STEM)

Detalles Bibliográficos
Autores principales: Wilck, M., Cornely, O., Ljungman, P., Cordonnier, C., Diego Velez, J., Dagan, R., Richmond, P., Chen, Q., Daus, C., Geddie, K., Sterling, T., Shekar, T., Musey, L., Buchwald, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430870/
http://dx.doi.org/10.1097/01.HS9.0000849160.61177.a4
_version_ 1784779896020533248
author Wilck, M.
Cornely, O.
Ljungman, P.
Cordonnier, C.
Diego Velez, J.
Dagan, R.
Richmond, P.
Chen, Q.
Daus, C.
Geddie, K.
Sterling, T.
Shekar, T.
Musey, L.
Buchwald, U.
author_facet Wilck, M.
Cornely, O.
Ljungman, P.
Cordonnier, C.
Diego Velez, J.
Dagan, R.
Richmond, P.
Chen, Q.
Daus, C.
Geddie, K.
Sterling, T.
Shekar, T.
Musey, L.
Buchwald, U.
author_sort Wilck, M.
collection PubMed
description
format Online
Article
Text
id pubmed-9430870
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94308702022-08-31 P1576: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU-STEM) Wilck, M. Cornely, O. Ljungman, P. Cordonnier, C. Diego Velez, J. Dagan, R. Richmond, P. Chen, Q. Daus, C. Geddie, K. Sterling, T. Shekar, T. Musey, L. Buchwald, U. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430870/ http://dx.doi.org/10.1097/01.HS9.0000849160.61177.a4 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Wilck, M.
Cornely, O.
Ljungman, P.
Cordonnier, C.
Diego Velez, J.
Dagan, R.
Richmond, P.
Chen, Q.
Daus, C.
Geddie, K.
Sterling, T.
Shekar, T.
Musey, L.
Buchwald, U.
P1576: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU-STEM)
title P1576: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU-STEM)
title_full P1576: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU-STEM)
title_fullStr P1576: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU-STEM)
title_full_unstemmed P1576: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU-STEM)
title_short P1576: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU-STEM)
title_sort p1576: a phase 3 randomized, double-blind, comparator-controlled study to evaluate safety, tolerability and immunogenicity of v114 pneumococcal vaccine in hematopoietic cell transplant recipients (pneu-stem)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430870/
http://dx.doi.org/10.1097/01.HS9.0000849160.61177.a4
work_keys_str_mv AT wilckm p1576aphase3randomizeddoubleblindcomparatorcontrolledstudytoevaluatesafetytolerabilityandimmunogenicityofv114pneumococcalvaccineinhematopoieticcelltransplantrecipientspneustem
AT cornelyo p1576aphase3randomizeddoubleblindcomparatorcontrolledstudytoevaluatesafetytolerabilityandimmunogenicityofv114pneumococcalvaccineinhematopoieticcelltransplantrecipientspneustem
AT ljungmanp p1576aphase3randomizeddoubleblindcomparatorcontrolledstudytoevaluatesafetytolerabilityandimmunogenicityofv114pneumococcalvaccineinhematopoieticcelltransplantrecipientspneustem
AT cordonnierc p1576aphase3randomizeddoubleblindcomparatorcontrolledstudytoevaluatesafetytolerabilityandimmunogenicityofv114pneumococcalvaccineinhematopoieticcelltransplantrecipientspneustem
AT diegovelezj p1576aphase3randomizeddoubleblindcomparatorcontrolledstudytoevaluatesafetytolerabilityandimmunogenicityofv114pneumococcalvaccineinhematopoieticcelltransplantrecipientspneustem
AT daganr p1576aphase3randomizeddoubleblindcomparatorcontrolledstudytoevaluatesafetytolerabilityandimmunogenicityofv114pneumococcalvaccineinhematopoieticcelltransplantrecipientspneustem
AT richmondp p1576aphase3randomizeddoubleblindcomparatorcontrolledstudytoevaluatesafetytolerabilityandimmunogenicityofv114pneumococcalvaccineinhematopoieticcelltransplantrecipientspneustem
AT chenq p1576aphase3randomizeddoubleblindcomparatorcontrolledstudytoevaluatesafetytolerabilityandimmunogenicityofv114pneumococcalvaccineinhematopoieticcelltransplantrecipientspneustem
AT dausc p1576aphase3randomizeddoubleblindcomparatorcontrolledstudytoevaluatesafetytolerabilityandimmunogenicityofv114pneumococcalvaccineinhematopoieticcelltransplantrecipientspneustem
AT geddiek p1576aphase3randomizeddoubleblindcomparatorcontrolledstudytoevaluatesafetytolerabilityandimmunogenicityofv114pneumococcalvaccineinhematopoieticcelltransplantrecipientspneustem
AT sterlingt p1576aphase3randomizeddoubleblindcomparatorcontrolledstudytoevaluatesafetytolerabilityandimmunogenicityofv114pneumococcalvaccineinhematopoieticcelltransplantrecipientspneustem
AT shekart p1576aphase3randomizeddoubleblindcomparatorcontrolledstudytoevaluatesafetytolerabilityandimmunogenicityofv114pneumococcalvaccineinhematopoieticcelltransplantrecipientspneustem
AT museyl p1576aphase3randomizeddoubleblindcomparatorcontrolledstudytoevaluatesafetytolerabilityandimmunogenicityofv114pneumococcalvaccineinhematopoieticcelltransplantrecipientspneustem
AT buchwaldu p1576aphase3randomizeddoubleblindcomparatorcontrolledstudytoevaluatesafetytolerabilityandimmunogenicityofv114pneumococcalvaccineinhematopoieticcelltransplantrecipientspneustem